170 related articles for article (PubMed ID: 34406442)
1. Normal bone health in young adults with 21-hydroxylase enzyme deficiency undergoing glucocorticoid replacement therapy.
Borges JH; de Oliveira DM; de Lemos-Marini SHV; Geloneze B; Guerra-Júnior G; Gonçalves EM
Osteoporos Int; 2022 Jan; 33(1):283-291. PubMed ID: 34406442
[TBL] [Abstract][Full Text] [Related]
2. Bone mineral density and body composition in prepubertal and adolescent patients with the classical form of 21-hydroxylase deficiency.
Sahakitrungruang T; Wacharasindhu S; Supornsilchai V; Srivuthana S; Kingpetch K
J Med Assoc Thai; 2008 May; 91(5):705-10. PubMed ID: 18672636
[TBL] [Abstract][Full Text] [Related]
3. Bone Mass in Young Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency.
Espinosa Reyes TM; Leyva González G; Domínguez Alonso E; Falhammar H
Horm Res Paediatr; 2021; 94(1-2):1-8. PubMed ID: 34044395
[TBL] [Abstract][Full Text] [Related]
4. Long-term glucocorticoid effect on bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Ceccato F; Barbot M; Albiger N; Zilio M; De Toni P; Luisetto G; Zaninotto M; Greggio NA; Boscaro M; Scaroni C; Camozzi V
Eur J Endocrinol; 2016 Aug; 175(2):101-6. PubMed ID: 27185866
[TBL] [Abstract][Full Text] [Related]
5. Bone mineral density in girls with classical congenital adrenal hyperplasia due to CYP21 deficiency.
Elnecave RH; Kopacek C; Rigatto M; Keller Brenner J; Sisson de Castro JA
J Pediatr Endocrinol Metab; 2008 Dec; 21(12):1155-62. PubMed ID: 19189689
[TBL] [Abstract][Full Text] [Related]
6. Bone mineral density is not significantly reduced in adult patients on low-dose glucocorticoid replacement therapy.
Koetz KR; Ventz M; Diederich S; Quinkler M
J Clin Endocrinol Metab; 2012 Jan; 97(1):85-92. PubMed ID: 21994966
[TBL] [Abstract][Full Text] [Related]
7. Association of androgen excess and bone mineral density in women with classical congenital adrenal hyperplasia with 21-hydroxylase deficiency.
Lee DH; Kong SH; Jang HN; Ahn CH; Lim SG; Lee YA; Kim SW; Kim JH
Arch Osteoporos; 2022 Mar; 17(1):45. PubMed ID: 35258698
[TBL] [Abstract][Full Text] [Related]
8. Cortical bone mineral density in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
El-Maouche D; Collier S; Prasad M; Reynolds JC; Merke DP
Clin Endocrinol (Oxf); 2015 Mar; 82(3):330-7. PubMed ID: 24862755
[TBL] [Abstract][Full Text] [Related]
9. Bone turnover and bone mineral density in patients with congenital adrenal hyperplasia.
Guo CY; Weetman AP; Eastell R
Clin Endocrinol (Oxf); 1996 Nov; 45(5):535-41. PubMed ID: 8977749
[TBL] [Abstract][Full Text] [Related]
10. Effect of long-term glucocorticoid therapy on bone mineral density of the patients with congenital adrenal hyperplasia.
Ünal S; Alikaşifoğlu A; Özön A; Gönç N; Kandemir N
Turk J Pediatr; 2020; 62(3):359-366. PubMed ID: 32558409
[TBL] [Abstract][Full Text] [Related]
11. Correlation of Bone Mineral Parameters with Anthropometric Measurements and the Effect of Glucocorticoids on Bone Mineral Parameters in Congenital Adrenal Hyperplasia.
Ganesh R; Suresh N; Janakiraman L; Ravikumar K
Indian J Pediatr; 2016 Feb; 83(2):126-30. PubMed ID: 26223873
[TBL] [Abstract][Full Text] [Related]
12. Bone density in young patients with congenital adrenal hyperplasia.
Mora S; Saggion F; Russo G; Weber G; Bellini A; Prinster C; Chiumello G
Bone; 1996 Apr; 18(4):337-40. PubMed ID: 8726391
[TBL] [Abstract][Full Text] [Related]
13. Impact of total cumulative glucocorticoid dose on bone mineral density in patients with 21-hydroxylase deficiency.
Chakhtoura Z; Bachelot A; Samara-Boustani D; Ruiz JC; Donadille B; Dulon J; Christin-Maître S; Bouvattier C; Raux-Demay MC; Bouchard P; Carel JC; Leger J; Kuttenn F; Polak M; Touraine P;
Eur J Endocrinol; 2008 Jun; 158(6):879-87. PubMed ID: 18390993
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density and fractures in congenital adrenal hyperplasia: Findings from the dsd-LIFE study.
Riehl G; Reisch N; Roehle R; Claahsen van der Grinten H; Falhammar H; Quinkler M
Clin Endocrinol (Oxf); 2020 Apr; 92(4):284-294. PubMed ID: 31886890
[TBL] [Abstract][Full Text] [Related]
15. Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia.
Falhammar H; Filipsson Nyström H; Wedell A; Brismar K; Thorén M
Eur J Endocrinol; 2013 Mar; 168(3):331-41. PubMed ID: 23211577
[TBL] [Abstract][Full Text] [Related]
16. Bone mineral density and bone turnover in Romanian children and young adults with classical 21-hydroxylase deficiency are influenced by glucocorticoid replacement therapy.
Zimmermann A; Sido PG; Schulze E; Al Khzouz C; Lazea C; Coldea C; Weber MM
Clin Endocrinol (Oxf); 2009 Oct; 71(4):477-84. PubMed ID: 19170706
[TBL] [Abstract][Full Text] [Related]
17. Fractures and bone mineral density in adult women with 21-hydroxylase deficiency.
Falhammar H; Filipsson H; Holmdahl G; Janson PO; Nordenskjöld A; Hagenfeldt K; Thorén M
J Clin Endocrinol Metab; 2007 Dec; 92(12):4643-9. PubMed ID: 17878254
[TBL] [Abstract][Full Text] [Related]
18. Reduced bone mineral density and increased bone metabolism rate in young adult patients with 21-hydroxylase deficiency.
Sciannamblo M; Russo G; Cuccato D; Chiumello G; Mora S
J Clin Endocrinol Metab; 2006 Nov; 91(11):4453-8. PubMed ID: 16926248
[TBL] [Abstract][Full Text] [Related]
19. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation.
Ghannam NN; Hammami MM; Bakheet SM; Khan BA
Calcif Tissue Int; 1999 Jul; 65(1):23-8. PubMed ID: 10369729
[TBL] [Abstract][Full Text] [Related]
20. Bone mineral density and body composition in congenital adrenal hyperplasia.
Cameron FJ; Kaymakci B; Byrt EA; Ebeling PR; Warne GL; Wark JD
J Clin Endocrinol Metab; 1995 Jul; 80(7):2238-43. PubMed ID: 7608286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
